Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Latest filing published 05 Jun 2026 for Acumen Pharmaceuticals, Inc..
Filing timeline
BuySaleKimberlee C. Drapkin
Insider track record
Disclosed buys
0
Disclosed sells
20
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kimberlee C. Drapkin: trading record in brief
Filings by Kimberlee C. Drapkin span 3 companies, the busiest being Jounce Therapeutics, Inc., Kineta, Inc./de and Acumen Pharmaceuticals, Inc. In total, 39 filings cover trades dated from 5 March 2018 to 3 June 2026.
The open-market record consists of 20 sales worth €688k, with no purchase. Besides market trades, the filings include 9 share grants and 7 option exercises.
The latest filing, published on 5 June 2026, reports a share grant in Acumen Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kimberlee C. Drapkin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
35,500 shares0Common StockSEC:0001628280-26-041276:0
13,794 sharesCommon StockSEC:0000950170-25-093062:0
12,500 shares@ US$0.611100.0% of flowCommon StockSEC:0000950170-25-090145:0
12,800 shares0Common StockSEC:0001576885-25-000081:0
25,751 sharesCommon StockSEC:0001640455-23-000107:0
6,315 shares@ US$1.109.9% of flowCommon StockSEC:0001640455-23-000009:0
27,500 shares0Common StockSEC:0001640455-22-000018:0
4,595 shares@ US$7.3082.0% of flowCommon StockSEC:0001640455-22-000009:0
8 of 8 declarations
